Medicinal and mechanistic overview of artemisinin in the treatment of human diseasesarticle Published on 2023-07-312024-09-01 Journal: Biomedicine & Pharmacotherapy [Category] 말라리아, [키워드] anticancer antimicrobial antioxidant Artemisinin Pharmacological mechanisms safety profile [Article Type] article
COVID-19 Vaccination Safety Profiles in Patients With Solid Tumour Cancers: A Systematic ReviewOriginal Article Published on 2023-03-152024-09-04 Journal: Clinical oncology (Royal College of Radiologists ( [Category] 대상포진, [키워드] Cancer COVID-19 safety profile SARS-CoV-2 solid tumour Vaccine [DOI] 10.1016/j.clon.2023.03.006 PMC 바로가기 [Article Type] Original Article
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric StudyObservational Study Published on 2023-02-012024-09-02 Journal: Journal of Clinical Immunology [Category] 대상포진, [키워드] Adverse reaction COVID-19 CVID IEI patients immunodeficiency safety profile Vaccines [DOI] 10.1007/s10875-022-01402-6 PMC 바로가기 [Article Type] Observational Study
Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohortArticle Published on 2022-12-012022-11-16 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome adverse event adverse events Breakthrough infection China clinical manifestation Cohort collected concerning conducted coronavirus Coronavirus disease 2019 COVID-19 COVID-19 vaccination decrease Efficacy enrolled fatigue feature grade 3 higher risk inactivated Inactivated vaccine Infection infections liver liver dysfunction Liver transplantation Mild myalgia occurred omicron participant Patient patients postoperative protection rate. recipient retrospective cohort Retrospective study Safe safety profile SARS-CoV-2 Seven vaccination Vaccine variant viral shedding were infected whole-virion SARS-CoV-2 vaccine [DOI] 10.1080/22221751.2022.2136535 PMC 바로가기
Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-siteComment Published on 2022-11-302023-07-09 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] Adverse reactions COVID-19 safety profile SARS-CoV-2 Side effects vaccination [DOI] 10.1080/21645515.2022.2090178 PMC 바로가기 [Article Type] Comment
Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseasesArticle Published on 2022-11-022022-11-15 Journal: Rheumatology (Oxford, England) [Category] SARS, 진단, [키워드] acute respiratory syndrome Administered Anti-RBD IgG antibody Antibody Response approval baseline biologic BNT162b2 mRNA BNT162b2 mRNA vaccine children Cohort cohort of patient Combined therapy coronavirus coronavirus disease COVID-19 disease Disease activity domain dose dose regimen effective elevated evaluated humoral Humoral response IgG antibody immunogenicity immunomodulatory IQR Local median mRNA vaccine of BNT162b2 paediatric rheumatic disease. pandemic Patient RBD receiving rheumatic disease safety profile SARS-CoV-2 second dose significantly lower Spike protein study period systemic side effect titre treated Treatment Vaccine were measured [DOI] 10.1093/rheumatology/keac140 PMC 바로가기
Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariantsArticle Published on 2022-11-012022-11-15 Journal: Virology [Category] SARS, 변종, 진단, [키워드] Antigen approach Beta Breakthrough infection cross-neutralization cross-neutralizing development Efficacy exhibited mice multivalent Multivalent protein vaccine Neutralizing omicron Omicron subvariants platform Protein risk rodents safety profile SARS-CoV-2 SARS-CoV-2 variant stability thermal thermal stability Vaccine Vaccine hesitancy Vaccines variant variants [DOI] 10.1016/j.virol.2022.09.003 PMC 바로가기
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trialArticle Published on 2022-11-012022-11-15 Journal: Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% confidence interval Administered adverse event approved assessment booster booster dose booster vaccination clinical trials Course COVID-19 COVID-19 vaccination COVID-19 vaccine cross-neutralization cross-neutralization. Day double-blind Effect fatigue Heterologous homologous humoral immunogenic immunogenicity incidence injection site pain Local Neutralizing antibodies neutralizing antibody outcome participant Participants Placebo placebo-controlled primary immunogenicity Randomized randomized placebo-controlled trial Recombinant spike protein reported robust Safe Safety safety profile saline placebo SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variants Serious Adverse Event Serious Adverse Events Seroconversion seroconversion rate shown SpikoGen subunit the placebo group Trial Vaccine was performed [DOI] 10.1111/imm.13540 PMC 바로가기
Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysisArticle Published on 2022-10-252022-11-15 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accelerate Characteristics clinical trial coronavirus disease Coverage COVID-19 COVID-19 vaccine cross-reactivity dose Dose fractionation effective Efficacy Evidence groups immunogenicity induce Meta-analysis mRNA NAb neutralizing antibody omicron predicted profile protein subunit vaccine reported Safe Safety safety profile SARS-CoV-2 vaccine Seroconversion Standard dose strain systematic review T cell T cell responses the vaccine Vaccine variant variants [DOI] 10.1186/s12916-022-02600-0 PMC 바로가기
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2Article Published on 2022-10-162022-11-15 Journal: Molecules [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Anti-inflammatory antioxidant antiviral drug applied caused clinical trial Combination contagious coronavirus COVID-19 COVID-19 disease COVID-19 severity disease Diseases drug effective Efficacy experiment Immunity immunomodulatory effects Infection melatonin mutations omicron Omicron variant (B.529) Other outbreak Outbreaks over oxidative oxidative stress Potential Prevent reduce reducing safety profile SARS-CoV-2 severe symptom severity shown significant effect the disease therapeutic Therapeutic approach therapeutic approach. therapeutic drug therapy treat Treatment unique Vaccine variant [DOI] 10.3390/molecules27206934 PMC 바로가기